Kevin Norrett - Feb 21, 2023 Form 4 Insider Report for CODEXIS, INC. (CDXS)

Role
Chief Operating Officer
Signature
/s/ Sriram Ryali, as Attorney-in-Fact for Kevin Norrett
Stock symbol
CDXS
Transactions as of
Feb 21, 2023
Transactions value $
$0
Form type
4
Date filed
2/21/2023, 07:28 PM
Previous filing
Mar 9, 2023
Next filing
Sep 12, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CDXS Common Stock Award $0 +22.5K $0.00 22.5K Feb 21, 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CDXS Stock Option (Right to Buy) Award $0 +67.5K $0.00 67.5K Feb 21, 2023 Common Stock 67.5K $5.44 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Restricted Stock Units ("RSUs") vest 1/3 annually from February 21, 2023 such that the RSUs will be fully vested on February 21, 2026. Each RSU represents a contingent right to receive one share of Codexis common stock.
F2 Option vests and becomes exercisable with respect to 25% of the shares subject thereto on February 21, 2024, with 1/48th of the shares vesting monthly thereafter, such that the option will be fully vested and exercisable on February 21, 2027, in each case, subject to continued service through the applicable vesting date.